If thyroid surgery for Graves' hyperthyroidism is delayed, should the saturated solution of potassium iodide be continued beyond the usual pre‑operative period, and what is the maximum safe duration?

SSKI Should NOT Be Continued Beyond 10 Days Before Surgery

If thyroid surgery is delayed, discontinue SSKI and resume methimazole to maintain euthyroid status until surgery can be performed. The standard 10-day preoperative iodine protocol is specifically designed as a short-term intervention immediately before surgery, and extending it beyond this period risks loss of efficacy and potential complications.

Why SSKI Cannot Be Extended

The Wolff-Chaikoff effect—the mechanism by which iodine blocks thyroid hormone synthesis—is transient and physiologically diminishes within 3 to 6 weeks 1. This means that prolonged iodine administration loses its therapeutic benefit as the thyroid gland "escapes" from iodine-induced blockade. The guidelines explicitly state that potassium iodide should be given "for 10 days before surgery" 2, with no provision for extension.

What To Do When Surgery Is Delayed

Immediate Action Plan:

• Stop SSKI if you've already started the 10-day course and surgery is postponed
• Resume methimazole (or continue if already on it) to maintain euthyroid status
• Restart SSKI only 10 days before the rescheduled surgery date

Rationale:

The primary goal is to have the patient euthyroid at the time of surgery to prevent thyroid storm 2. Methimazole is the appropriate long-term agent for maintaining euthyroid status during delays. SSKI's role is specifically to:

1. Decrease thyroid vascularity
2. Reduce intraoperative blood loss
3. Provide rapid additional control in the immediate preoperative period 2

Critical Timing Considerations

The 10-day window is not arbitrary—it represents the optimal period where:

• Iodine's inhibitory effects are maximal
• The Wolff-Chaikoff escape phenomenon has not yet occurred
• Thyroid vascularity is maximally reduced for surgical benefit

Research shows that iodine's effects on thyroid hormone levels peak at 2-3 weeks, but then may normalize even at 5 weeks in some patients 3. More concerning, when iodine is discontinued after prolonged use, deterioration in thyroid function can occur 4, potentially destabilizing a patient who was previously well-controlled.

Important Caveats

Exception for Antithyroid Drug Intolerance:

If the patient developed agranulocytosis or severe hepatotoxicity from methimazole, SSKI can be used as a bridge therapy for longer periods (typically with beta-blockade), but this is an exceptional circumstance requiring close monitoring 5. Even in this scenario, surgery should be expedited rather than prolonging iodine therapy indefinitely.

The French Perspective:

European guidelines note that iodide's "only certain role" in Graves' disease is for surgical preparation when severe side effects contraindicate antithyroid drugs 1. They emphasize lack of European experience with prolonged iodide use and recommend against it outside of controlled trials.

Practical Algorithm

If surgery is delayed:

1. Day 1-10 of SSKI started → Stop SSKI, resume/continue methimazole
2. Monitor thyroid function every 2-4 weeks during delay
3. 10 days before new surgery date → Restart SSKI (assuming patient is euthyroid on methimazole)
4. If patient cannot tolerate methimazole → Consider beta-blockade + SSKI as temporary measure, but expedite surgery (do not extend beyond 2-3 weeks)

The key principle: SSKI is a short-term perioperative adjunct, not a maintenance therapy. Attempting to extend it beyond 10 days risks both loss of efficacy due to physiologic escape and potential rebound thyrotoxicosis upon discontinuation 4, 6.